2[1]Adams MR, Mcoredie R, Jessup W, et al. Oral L-arginine improves endotheliun- dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease[J]. Atherosclerosis, 1997, 129: 261-269.
3[2]Celermajer DS, Sorensen KE, Gooch V,et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis [J]. Lancet.1992, 340: 1111-1115.
4[3]Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor [J]. Nature, 1987, 327:524-526.
5[4]Inoue T, Tomoike H, Hisano K, et al. Endothelium determines flow-dependent dilation of the epicardial coronary artery in dogs[ J]. J Am Coll Cardiol, 1988,11: 187-191.
6[5]Panza JA, Casino PR, Badar DM, et al. Effects of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular telaxation in normal subjects and in patients with essential hypertension[ J ]. Circulation, 1993, 87: 1475-1481.
7[6]Shiode N, Morishima N, Nalayama K, et al. Flow-tnediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis[J]. JAm Coll Cardiol, 1996, 27: 304-310.
8[7]BSger RH. Bode-Boger SM, Szuba A, et al. Asymmetric dimethylarginine(ADMA): a noval risk factor for endothelial dysfunction-its role in hypercholesterolemia[J]. Circulation, 1998, 98: 1842-1847.
9[8]Nishiksea Y, Stepp DW, Chilian WM. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation[J]. Am J Physiol, 1999, 277(3 Pt 2):H1252-H1259.
10[9]Urakami-Harasswa R, Shimokawa H, Nakashima M, et al. Impertance of endothelium-derived hyperpolarizing factor in human arteries [J]. J Clin lnvest.1997, 100: 2793-2799.
